Medivir AB (publ) (STO:MVIR)
1.044
-0.080 (-7.12%)
Nov 20, 2026, 5:29 PM CET
Medivir AB Market Cap
Medivir AB has a market cap or net worth of 651.64 million as of November 20, 2026. It is the 27,709th most valuable company in the world and the 354th biggest in Sweden. Its market cap has increased by 1,220.35% in one year.
Market Cap
651.64M
Enterprise Value
407.54M
Revenue
8.51M
Global Rank
Country Rank
#354 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 30, 1999, Medivir AB's market cap has increased from 643.11M to 651.64M, an increase of 1.33%. That is a compound annual growth rate of 0.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 651.64M | 255.11% |
| Dec 30, 2025 | 183.51M | -42.39% |
| Dec 30, 2024 | 318.56M | 100.20% |
| Dec 29, 2023 | 159.12M | -71.16% |
| Dec 30, 2022 | 551.67M | -11.61% |
| Dec 30, 2021 | 624.11M | 209.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 1.08B |
| Infant Bacterial Therapeutics AB | 934.92M |
| AlzeCure Pharma AB | 783.26M |
| SynAct Pharma AB | 727.98M |
| Oncopeptides AB | 648.27M |
| Xspray Pharma AB | 482.70M |
| FluoGuide | 482.30M |
| Sprint Bioscience AB | 388.30M |